Nursing–Pharmacy Collaboration in Early Identification and Prevention of Medication-Related Patient Deterioration in Hospitalized Adults
DOI:
https://doi.org/10.22399/ijcesen.4691Keywords:
Nursing-Pharmacy Collaboration, Interprofessional Collaboration, Medication Safety, Patient Deterioration, Adverse Drug EventsAbstract
Effective interprofessional collaboration between nurses and pharmacists is a critical strategy for enhancing patient safety and preventing medication-related deterioration in hospitalized adults. This synergistic partnership leverages the nurse's continuous bedside presence and holistic assessment skills—essential for detecting early, subtle signs of clinical decline—with the pharmacist's specialized expertise in pharmacotherapy, risk assessment, and medication regimen optimization. By moving beyond professional silos through structured mechanisms such as joint patient reviews, shared monitoring protocols, and collaborative quality improvement initiatives, this team-based approach facilitates the early identification of adverse drug events and proactive mitigation of pharmacological risks. This integrated model addresses a significant source of preventable patient harm, ultimately leading to improved clinical outcomes, reduced healthcare costs, and a more robust safety culture within hospital settings.
References
[1] Alper, E., O'Malley, T.A., Greenwald, J. (2020). Hospital discharge and readmission. UpToDate.
[2] Dennis S., May J., Perkins D., Zwar N., Sibbald B., Hasan I. What evidence is there to support skill mix changes between GPs, pharmacists and practice nurses in the care of elderly people living in the community? Australia & New Zealand Health Policy. 2009;6(7).
[3] Chapman E., Haby M.M., Toma T.S., de Bortoli M.C., Illanes E., Oliveros M.J., Barreto J.O. Knowledge translation strategies for dissemination with a focus on healthcare recipients: an overview of systematic reviews. Implementation Sci. 2020;15(1).
[4] Peters M., Godfrey C., Khalil H., Mcinerney P., Parker D., Soares C. Guidance for conducting systematic scoping reviews. Int. J. Evid. Based Healthc. 2015;13.
[5] Hunt R. Introduction to Community-based Nursing. 5th Ed. Lippincott Williams & Wilkins; 2012.
[6] Godfrey, C.M., Harrison, M.B., Lang, A., Macdonald, M., Leung, T., & Swab, M. (2013). Homecare safety and medication management with older adults: a scoping review of the quantitative and qualitative evidence.
[7] McLean D.L., McAlister F.A., Johnson J.A. A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN) Arch. Intern. Med. 2008;168:2355–2361.
[8] Omboni S., Caserini M. Effectiveness of pharmacist’s intervention in the management of cardiovascular diseases. Open Heart. 2018;5(1).
[9] Flynn A., Anderson C. Meaningful collaboration. Nurs. Manag. 2012;43(12):2–5.
[10] LeBlanc R.G., Choi J. Optimizing medication safety in the home. Home Healthc. Now. 2015;33(6):313–319.
[11] Hamano J., Ozone S., Tokuda Y. A comparison of estimated drug costs of potentially inappropriate medications between older patients receiving nurse home visit services and patients receiving pharmacist home visit services: a cross-sectional and propensity score analysis. BMC Health Serv. Res. 2015;15.
[12] Bell H.T., Granas A.G., Enmarker I., Omli R., Steinsbekk A. Nurses’ and pharmacists’ learning experiences from participating in interprofessional medication reviews for elderly in primary health care—A qualitative study. BMC Fam. Pract. 2017;18:1–9.
[13] Foubert K., Mehuys E., Claes L., Van Den Abeele D., Haems M., Somers A., Petrovic M., Boussery K. A shared medication scheme for community dwelling older patients with polypharmacy receiving home health care: role of the community pharmacist. Acta Clinica Belgica: Int. J. Clin. Laboratory Med. 2019;74(5):326–333.
[14] Noble H., Smith J. Reviewing the literature: choosing a review design. Evid. Based Nurs. 2018;21:39–41.
[15] Bayraktar-Ekincioglu A., Kucuk E. The differences in the assessments of side effects at an oncology outpatient clinic. Int. J. Clin. Pharm. 2018;40(2):386–393.
[16] Elliott R.A., Lee C.Y., Beanland C., Goeman D.P., Petrie N., Petrie B., Vise F., Gray J. Development of a clinical pharmacy model within an australian home nursing service using co-creation and participatory action research: the visiting pharmacist (ViP) study. BMJ Open. 2017;7(11).
[17] D’Amour D., Ferrada-Videla M., San Martin Rodriguez L., Beaulieu M.-.D. The Conceptual basis for interprofessional collaboration: core concepts and theoretical frameworks. J. Interprof. Care. 2005;19(S1):116–131.
[18] Pherson E., Roth J., Nkimbeng M., Boyd C., Szanton S.L. Ensuring safe and optimal medication use in older community residents: collaboration between a nurse and a pharmacist. Geriatr. Nurs. (Minneap) 2018;39(5):554–559.
[19] Celio J., Ninane F., Bugnon O., Schneider M.P. Pharmacist-nurse collaborations in medication adherence-enhancing interventions: a review. Patient Educ. Couns. 2018;101(7):1175–1192.
[20] Saint-Pierre C., Herskovic V., Sepúlveda M. Multidisciplinary collaboration in primary care: a systematic review. Fam. Pract. 2018;35(2):132–141.
[21] Lyson, H.C., Sharma, A.E., Cherian, R., Patterson, E.S., McDonald, K.M., Lee, S.-.Y., & Sarkar, U. (2019). A qualitative analysis of outpatient medication use in community settings. J. Patient Safety.
[22] Banning M. Medication management: older people and nursing. Nurs. Older People. 2005;17(7):20–23.
[23] Lee C.Y., Goeman D., Beanland C., Elliott R.A. Challenges and barriers associated with medication management for home nursing clients in Australia: a qualitative study combining the perspectives of community nurses. Community Pharmacists and GPs. Family Practice. 2018;36(3):332–342.
[24] Ploeg J., Canesi M., D Fraser K., McAiney C., Kaasalainen S., Markle-Reid M., Dufour S., Garland Baird L., Chambers T. Experiences of community-dwelling older adults living with multiple chronic conditions: a qualitative study. BMJ Open. 2019;9(3).
[25] Santschi V., Wuerzner G., Chiolero A., Burnand B., Schaller P., Cloutier L., Paradis G., Burnier M. Team-based care for improving hypertension management among outpatients (TBC-HTA): study protocol for a pragmatic randomized controlled trial. BMC Cardiovasc. Disord. 2017;17(1):39.
[26] Canadian Patient Safety Institute [CPSI]. (2017). Safety Improvement Projects.
[27] Porter A.C., Fitzgibbon M.L., Fischer M.J., Gallardo R., Berbaum M.L., Lash J.P., Castillo S., Schiffer L., Sharp L.K., Tulley J., Arruda J.A., Hynes D.M. Rationale and design of a patient-centered medical home intervention for patients with end-stage renal disease on hemodialysis. Contemp. Clin. Trials. 2015;42:1–8.
[28] Hadi M.A., Alldred D.P., Briggs M., Closs S.J. A combined nurse-pharmacist managed pain clinic: joint venture of public and private sectors. Int. J. Clin. Pharm. 2012;34(1):1–3.
[29] Institute for Safe Medication Practices Canada [ISMP Canada]. (2007). Definitions.
[30] Perraudin C., Bourdin A., Spertini F., Berger J., Bugnon O. Switching patients to home-based subcutaneous immunoglobulin: an economic evaluation of an interprofessional drug therapy management program. J. Clin. Immunol. 2016;36(5):502–510.
[31] Setter S.M., Corbett C.F., Neumiller J.J., Gates B.J., Sclar D.A., Sonnett T.E. Effectiveness of a pharmacist—nurse intervention on resolving medication discrepancies for patients transitioning from hospital to home health care. Am. J. Health-Syst. Pharmacy. 2009;66(22):2027–2031.
[32] Levac D., Colquhoun H., O’Brien K.K. Scoping studies: advancing the methodology. Implementation Sci. 2010;69(5).
[33] Ellenbecker C.H., Samia L., Cushman M.J., Alster K. Chapter 13. Patient Safety and Quality in Home Health Care. 2009;1:40.
[34] O'Daniel., M. & Rosenstein, A.H. (2008). Professional communication and team collaboration. In R.G. Hughes (Ed.), Patient Safety and Quality: An Evidence-Based Handbook for Nurses (Chapter 33). Agency for Healthcare Research and Quality (US).
[35] Meyer-Massetti C., Hofstetter V., Hedinger-Grogg B., Meier C.R., Guglielmo B.J. Medication-related problems during transfer from hospital to home care: baseline data from Switzerland. Int. J. Clin. Pharm. 2018;40(6):1614–1620.
[36] Jones C.D., Jones J., Richard A., Bowles K., Lahoff D., Boxer R.S., Masoudi F.A., Coleman E.A., Wald H.L. Connecting the dots”: a qualitative study of home health nurse perspectives on coordinating care for recently discharged patients. J. Gen. Intern. Med. 2017;32(10):1114–1121.
[37] Braungart C., Watson A., Rubin R. The effects of interprofessional collaboration on nurse managed warfarin program. J. Interprofessional Education & Practice. 2018;13:56–58.
[38] Engel J., Prentice D. The ethics of interprofessional collaboration. Nurs. Ethics. 2013;20(4):426–435.
[39] Hadi M.A., Alldred D.P., Briggs M., Marczewski K., Closs S.J. Effectiveness of a community based nurse-pharmacist managed pain clinic: a mixed-methods study. Int. J. Nurs. Stud. 2016;53:219–227.
[40] Lee C.Y., Beanland C., Goeman D., Petrie N., Petrie B., Vise F., Gray J., Elliott R.A. Improving medication safety for home nursing clients: a prospective observational study of a novel clinical pharmacy service— the visiting pharmacist (ViP) study. J. Clin. Pharmacy & Therapeutics. 2018;43(6):813–821.
[41] Arksey H., O’Malley L. Scoping studies: towards a methodological framework. Int. J. Soc. Res. Methodol. 2005;8(1):19–32.
[42] Hohl C.M., Woo S.A., Cragg A., Wickham M.E., Ackerley C., Scheuermeyer F., Villanyi D. Repeat adverse drug events associated with outpatient medications: a descriptive analysis of 3 observational studies in British Columbia. Canada. CMAJ Open. 2019;7(3):E446–E453.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 International Journal of Computational and Experimental Science and Engineering
This work is licensed under a Creative Commons Attribution 4.0 International License.
